Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 404,642 | 446,120 | 497,528 | 476,487 | 413,787 |
| Cost of Goods | 299,393 | 363,040 | 304,120 | 276,382 | 235,492 |
| Gross Profit | 105,249 | 83,080 | 193,408 | 200,105 | 178,295 |
| Operating Expenses | 124,555 | 177,480 | 170,248 | 125,932 | 359,849 |
| Operating Income | -18,913 | -94,360 | 23,280 | 74,555 | -181,062 |
| Interest Expense | 43,886 | 43,281 | 42,880 | 43,018 | 36,622 |
| Other Income | 6,572 | 4,461 | 4,794 | -8,963 | -44,822 |
| Pre-tax Income | -56,227 | -133,180 | -14,806 | 22,574 | -262,506 |
| Income Tax | -5,701 | -8,428 | 5,524 | 5,109 | -12,416 |
| Net Income Continuous | -50,526 | -124,752 | -20,330 | 17,465 | -250,090 |
| Minority Interests | -33,624 | -76,871 | -63,097 | 10,513 | -30,645 |
| Net Income | $-16,902 | $-47,881 | $42,767 | $6,952 | $-219,445 |
| EPS Basic Total Ops | -0.13 | -0.37 | -0.06 | 0.05 | -0.15 |
| EPS Basic Continuous Ops | -0.39 | -0.98 | 0.25 | 0.14 | -1.97 |
| EPS Diluted Total Ops | -0.13 | -0.37 | -0.06 | 0.05 | -0.15 |
| EPS Diluted Continuous Ops | -0.39 | -0.98 | 0.25 | 0.14 | -1.97 |
| EBITDA(a) | $33,410 | $-7,498 | $82,835 | $119,211 | $-147,509 |